切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2023, Vol. 17 ›› Issue (04) : 306 -310. doi: 10.3877/cma.j.issn.1674-0793.2023.04.016

综述

喉前淋巴结转移对甲状腺乳头状癌诊疗价值的研究进展
樊逸隽, 杨枫, 王玮, 殷鹤英, 刘俊()   
  1. 201620 南京医科大学附属上海一院临床医学院;201600 上海松江区中心医院
    201600 上海松江区中心医院
    201620 南京医科大学附属上海一院临床医学院;201620 上海交通大学医学院附属第一人民医院乳腺甲状腺外科
  • 收稿日期:2022-11-01 出版日期:2023-08-01
  • 通信作者: 刘俊

Research progress in the diagnostic and therapeutic value of Delphian lymph node metastasis in papillary thyroid carcinoma

Yijun Fan, Feng Yang, Wei Wang, Heying Yin, Jun Liu()   

  1. Clinical Medical College of Shanghai First Affiliated Hospital of Nanjing Medical University, Shanghai 201620, China; Shanghai Songjiang District Central Hospital, Shanghai 201600, China
    Shanghai Songjiang District Central Hospital, Shanghai 201600, China
    Clinical Medical College of Shanghai First Affiliated Hospital of Nanjing Medical University, Shanghai 201620, China; Department of Mammary and Thyroid Surgery, the First People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China
  • Received:2022-11-01 Published:2023-08-01
  • Corresponding author: Jun Liu
引用本文:

樊逸隽, 杨枫, 王玮, 殷鹤英, 刘俊. 喉前淋巴结转移对甲状腺乳头状癌诊疗价值的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(04): 306-310.

Yijun Fan, Feng Yang, Wei Wang, Heying Yin, Jun Liu. Research progress in the diagnostic and therapeutic value of Delphian lymph node metastasis in papillary thyroid carcinoma[J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(04): 306-310.

喉前淋巴结(DLN)对于甲状腺乳头状癌(PTC)的意义一直存在争议。有研究者认为其是PTC的前哨淋巴结,但也有认为其对于PTC进展和预后的判断完全不可靠。众多研究认为PTC肿瘤直径>1 cm、腺外侵犯、淋巴管侵犯、肿瘤位于腺叶上1/3和(或)峡部是DLN转移的重要风险因素,同时DLN转移在预测其他中央区淋巴结转移(CLNM)、对侧CLNM、颈侧区淋巴结转移、对侧腺叶隐匿性癌方面具有非常重要的意义,能提供更多关于手术及淋巴结清扫范围的建议。本文针对PTC中DLN转移风险因素作一综述。

The significance of Delphian lymph node (DLN) for papillary thyroid carcinoma (PTC) has been controversial. Some investigators considered DLN as a sentinel lymph node in PTC, but others believed that it is completely unreliable in judging the progress and prognosis of PTC. In this article, we summarized the risk factors of DLN metastasis (DLNM) in PTC in detail. Numerous research studies have identified PTC tumor diameter greater than 1 cm, extrathyroidal extension, lymphovascular invasion, and tumor location in the upper third of the glandular lobe and/or isthmus as important risk factors for DLNM. At the same time, DLNM is of great significance in predicting other central lymph node metastasis (CLNM), contralateral CLNM, lateral cervical lymph node metastasis, and occult thyroid carcinoma in the contralateral glandular lobe. This can give more advice on the extent of surgery and lymph node dissection.

[14]
Chai YJ, Kim SJ, Choi JY, et al. Papillary thyroid carcinoma located in the isthmus or upper third is associated with Delphian lymph node metastasis[J]. World J Surg, 2014, 38(6): 1306-1311.
[15]
Tan Z, Ge MH, Zheng CM, et al. The significance of Delphian lymph node in papillary thyroid cancer[J]. Asia-Pacific J Clin Oncol, 2017, 13(5): e389-e393.
[16]
Yan Y, Wang Y, Liu N, et al. Predictive value of the Delphian lymph node in cervical lymph node metastasis of papillary thyroid carcinoma[J]. Eur J Surg Oncol, 2021, 47(7): 1727-1733.
[17]
Zhao J, Zhang Y, Zheng X. Clinicopathological characteristics of papillary thyroid cancer located in the isthmus with Delphian lymph node metastasis[J]. Br J Oral Maxillofac Surg, 2022, 60(5): 635-638.
[18]
Wang B, Wen XZ, Zhang W, et al. Clinical implications of Delphian lymph node metastasis in papillary thyroid carcinoma: A single-institution study, systemic review and meta-analysis[J]. J Otolaryngol Head Neck Surg, 2019, 48(1): 42.
[19]
Harries V, Wang LY, McGill M, et al. Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma?[J]. Surgery, 2020,167(1): 10-17.
[20]
Sezer A, Celik M, Yilmaz Bulbul B, et al. Relationship between lymphovascular invasion and clinicopathological features of papillary thyroid carcinoma[J]. Bosn J Basic Med Sci, 2017, 17(2): 144-151.
[21]
陈洁, 王亚兵, 陈晓林, 等. Delphian淋巴结在甲状腺乳头状癌中的临床价值[J]. 国际外科学杂志, 2016, 43(2): 95-99.
[22]
Huang J, Sun W, Zhang H, et al. Use of Delphian lymph node metastasis to predict central and lateral involvement in papillary thyroid carcinoma: A systematic review and meta-analysis[J]. Clin Endocrinol (Oxf), 2019, 91(1): 170-178.
[23]
Chen Q, Wei T, Wang XL, et al. The total number of prelaryngeal and pretracheal lymph node metastases: is it a reliable predictor of contralateral central lymph node metastasis in papillary thyroid carcinoma?[J]. J Surg Res, 2017, 214: 162-167.
[24]
Kim DH, Kim SW, Hwang SH. Predictive value of Delphian lymph node metastasis in the thyroid cancer[J]. Laryngoscope, 2021, 131(9): 1990-1996.
[25]
周静, 胡代星, 苏新良, 等. cN0单侧甲状腺乳头状癌中央区各亚区与患侧侧区淋巴结转移关系的探讨[J]. 中华内分泌外科杂志, 2019, 13(1): 31-35.
[26]
Kim SY, Kim SM, Chang H, et al. Lateral neck metastases in the ipsilateral and contralateral compartments of papillary thyroid carcinoma located in one lobe[J]. ANZ J Surg, 2019, 89(11): E498-E501.
[27]
Chen ML, Xu D, Yan XQ, et al. Delphian lymph node metastasis predicts occult contralateral carcinoma for unilateral papillary thyroid carcinoma patients with contralateral benign nodules[J]. Asian J Surg, 2023, 46(1): 156-159.
[28]
梁理娟, 蒙万添, 赖华强, 等. 彩色多普勒超声检查在甲状腺恶性肿瘤的诊断价值 [J/CD]. 中华消化病与影像杂志(电子版), 2022, 12(5): 274-277.
[1]
Shaha AR, Tuttle RM. Delphian node-A sentinel node in thyroid cancer?[J]. J Surg Oncol, 2021, 123(7): 1529-1530.
[2]
Oh EM, Chung YS, Lee YD. Clinical significance of Delphian lymph node metastasis in papillary thyroid carcinoma[J]. World J Surg, 2013, 37(11): 2594-2599.
[3]
Shaha AR, Tuttle RM, Wreesmann VB. Management of the contralateral central neck in differentiated thyroid cancer: A contentious issue[J]. Eur J Surg Oncol, 2021, 47(4): 717-719.
[4]
Isaacs JD, McMullen TP, Sidhu SB, et al. Predictive value of the Delphian and level Ⅵ nodes in papillary thyroid cancer[J]. ANZ J Surg, 2010, 80(11): 834-838.
[5]
Lee YC, Shin SY, Kwon KH, et al. Incidence and clinical characteristics of prelaryngeal lymph node metastasis in papillary thyroid cancer[J]. Eur Arch Otorhinolaryngol, 2013, 270(9): 2547-2550.
[6]
白云城, 程若川. 甲状腺癌淋巴引流规律与研究方法[J]. 国际外科学杂志, 2012, 39(2): 101-103.
[7]
Isaacs JD, Lundgren CI, Sidhu SB, et al. The Delphian lymph node in thyroid cancer[J]. Ann Surg, 2008, 247(3): 477-482.
[8]
Zhu Y, Lin J, Yan Y, et al. Delphian lymph node metastasis is a novel indicator of tumor aggressiveness and poor prognosis in papillary thyroid cancer[J]. J Surg Oncol, 2021, 123(7): 1521-1528.
[9]
丁金旺, 彭友, 潘钢, 等. 甲状腺乳头状癌Delphian淋巴结清扫的临床意义[J]. 中华内分泌外科杂志, 2020, 14(4): 290-294.
[10]
Kim WW, Yang SI, Kim JH, et al. Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma[J]. World J Surg Oncol, 2012, 10(1): 226.
[11]
刘威, 王聪, 王正林, 等. 单侧甲状腺乳头状癌Delphian淋巴结转移的发生率及其临床意义[J]. 外科理论与实践, 2021, 26(5): 445-448.
[12]
Iyer NG, Kumar A, Nixon IJ, et al. Incidence and significance of Delphian node metastasis in papillary thyroid cancer[J]. Ann Surg, 2011, 253(5): 988-991.
[13]
Zheng G, Zhang H, Hao S, et al. Patterns and clinical significance of cervical lymph node metastasis in papillary thyroid cancer patients with Delphian lymph node metastasis[J]. Oncotarget, 2017, 8(34): 57089-57098.
[1] 孙帼, 谢迎东, 徐超丽, 杨斌. 超声联合临床特征的列线图模型预测甲状腺乳头状癌淋巴结转移的价值[J]. 中华医学超声杂志(电子版), 2023, 20(07): 734-742.
[2] 陈启阳, 刘玉江, 刘金苹, 谭小蕖, 钱林学, 胡向东. 基于超声造影的预测模型对甲状腺乳头状癌颈中央区淋巴结转移的诊断价值[J]. 中华医学超声杂志(电子版), 2023, 20(04): 442-448.
[3] 李素娟, 丁文波, 武心萍, 邓学东. 被膜侵犯的甲状腺微小乳头状癌发生颈部淋巴结转移的超声相关危险因素分析[J]. 中华医学超声杂志(电子版), 2023, 20(04): 455-461.
[4] 刘星辰, 刘娟, 魏宝宝, 刘洁, 刘辉. XIAP与XAF1异常表达与卵巢癌的相关性分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 419-427.
[5] 张永博, 张亮, 陈浏阳, 戴睿, 孙华, 杨盛, 孟博, 彭晴. 线粒体与椎间盘退变[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 265-269.
[6] 李雄雄, 周灿, 徐婷, 任予, 尚进. 初诊导管原位癌伴微浸润腋窝淋巴结转移率的Meta分析[J]. 中华普通外科学文献(电子版), 2023, 17(06): 466-474.
[7] 徐成, 王璐璐, 王少华. 洗脱液甲状腺球蛋白在甲状腺乳头状癌转移淋巴结中的应用[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 701-704.
[8] 袁育韬, 邢金琳, 谢克飞, 殷凯. CT征象及BRAFV600E基因突变与甲状腺乳头状癌中央区淋巴结转移的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 611-614.
[9] 单兴利, 王栋, 邢念增, 肖泽均, 李亚健. 68Ga-PSMA-PET/CT对前列腺癌盆腔淋巴结转移诊断价值的研究[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 214-218.
[10] 李芳, 孙海云. 风险因素护理干预对合并失代偿性肝硬化的腹股沟疝患者Lichtenstein术围手术期应用效果[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(04): 477-480.
[11] 张林, 刘芳, 赵静, 刘勇, 周青. 远程康复在慢性阻塞性肺疾病患者肺康复中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 601-604.
[12] 李丹阳, 李满祥. 肠道菌群失调在肺动脉高压发病中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 432-434.
[13] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[14] 樊佩琦, 闫燕, 李晓霞, 武玲宇, 郭罡玲, 李静, 王利华. 2020年山西省腹膜透析患者贫血的流行病学调查及相关因素分析[J]. 中华肾病研究电子杂志, 2023, 12(03): 121-126.
[15] 吴一菡, 雷章, 卢宏达. MUC16/CA125在良恶性肿瘤诊治中的作用及其研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(05): 591-595.
阅读次数
全文


摘要